ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

70
Analysis
Health CareHong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
Refresh
08 May 2020 10:04

Hong Kong Buyback League Table: Evergrande, Yichang HEC, Yanzhou Coal

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
314 Views
Share
20 Jan 2020 09:33

Hong Kong Buyback Weekly: Xingyi Glass, Yichang HEC, Consun Pharma

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
316 Views
Share
25 Nov 2019 14:40

Hong Kong Buyback Weekly: Yichang HEC, Weimob and China Literature

In the past 7 days, the top 3 companies that repurchased the most shares from the market were Yichang Hec Changjiang Pharm (1558 HK) (HKD 42.3...

Logo
313 Views
Share
bullishMeituan
18 Nov 2019 22:40

HK Connect Flows: Close Meituan/Elong Trade with a 14.5% Profit

In our weekly HK Connect Flow series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...

Logo
322 Views
Share
18 Nov 2019 10:33

Hong Kong Buyback Weekly: Yichang HEC, Viva Biotech, China Literature Led the Buybacks

In the past 7 days, the top 3 companies that repurchased the most shares from the market were Yichang Hec Changjiang Pharmaceutical Co., Ltd. (1558...

Logo
266 Views
Share
x